“IN-VITRO EFFICACY OF PIPERACILLIN SULBACTAM AGAINST MULTIDRUG-RESISTANT PSEUDOMONAS AERUGINOSA: A COMPARATIVE STUDY WITH PIPERACILLIN TAZOBACTAM AND CEFOPERAZONE SULBACTAM”. Frontier in Medical and Health Research, vol. 4, no. 3, Mar. 2026, pp. 4971-7, https://fmhr.net/index.php/fmhr/article/view/3904.